These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is. Tumanan-Mendoza BA, Dans AL, Villacin LL, Mendoza VL, Rellama-Black S, Bartolome M, Ragual J, Flor B, Valdez J. J Clin Epidemiol; 2007 Jun; 60(6):547-53. PubMed ID: 17493508 [Abstract] [Full Text] [Related]
6. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo. Rake EC, Breeze E, Fletcher AE. J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989 [Abstract] [Full Text] [Related]
7. Prophylactic effect of imidapril on stroke in stroke-prone spontaneously hypertensive rats. Ogiku N, Sumikawa H, Hashimoto Y, Ishida R. Stroke; 1993 Feb; 24(2):245-52. PubMed ID: 8421827 [Abstract] [Full Text] [Related]
9. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension. Breeze E, Rake EC, Donoghue MD, Fletcher AE. J Hum Hypertens; 2001 Dec; 15(12):857-62. PubMed ID: 11773988 [Abstract] [Full Text] [Related]
10. Different effects of imidapril and enalapril on aminopeptidase P activity in the mouse trachea. Sakamoto K, Sugimoto K, Sudoh T, Fujimura A. Hypertens Res; 2005 Mar; 28(3):243-7. PubMed ID: 16097368 [Abstract] [Full Text] [Related]
11. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs. Nishiyama S, Kanno K, Yoneda H, Yano K, Yamaguchi I. Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673 [Abstract] [Full Text] [Related]
13. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats. Yamanaka K, Takehara N, Murata K, Banno K, Sato T. J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331 [Abstract] [Full Text] [Related]
14. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. Tikkanen I, Omvik P, Jensen HA. J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133 [Abstract] [Full Text] [Related]
15. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group. Tanser PH, Campbell LM, Carranza J, Karrash J, Toutouzas P, Watts R. Am J Hypertens; 2000 Feb; 13(2):214-8. PubMed ID: 10701823 [Abstract] [Full Text] [Related]
16. Studies on the magnitude and the mechanism of cough potentiation by angiotensin-converting enzyme inhibitors in guinea-pigs: involvement of bradykinin in the potentiation. Takahama K, Araki T, Fuchikami J, Kohjimoto Y, Miyata T. J Pharm Pharmacol; 1996 Oct; 48(10):1027-33. PubMed ID: 8953504 [Abstract] [Full Text] [Related]